Actuate Therapeutics Inc (ACTU)
$0.34 -9.68% Close Oct 30, 2026 Live
Actuate Therapeutics stock today
Actuate Therapeutics closed at $0.34 on October 30, 2026, down 9.68% on the day. Over the past year it returned -94.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $8.00 million.
$2.50$5.00$7.50
NovJan 2026MarMayJulSep
| Period | ACTU | S&P 500 (SPY) |
|---|---|---|
| 1 month | -57.0% | -0.9% |
| 3 months | -71.4% | +2.1% |
| Year to date | -94.5% | +11.7% |
| 1 year | -94.9% | +12.4% |
Key statistics
- Market value
- $8.00M
- 52-week range
- $0.34 to $7.63
- Next report
- Nov 12, 2026 (estimated)
About Actuate Therapeutics
Actuate Therapeutics develops therapies for unmet medical needs in ophthalmology and neurology.
Sector: Health Care
More on Actuate Therapeutics
- Returns: what $1,000 became$1,000 one year ago is $50.93 today
No forecast, no recommendation. This page describes Actuate Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.